SCHEMBL19033045

SCHEMBL19033045

Cc1c(CC(=O)C(C)C)c(=O)oc2cc(N)c(S(=O)(=O)O)cc12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.41
RAB9A P51151 4/20 0.41
KDM4E B2RXH2 3/20 0.41
MAPT P10636 2/20 0.41
KMT2A Q03164 4/20 0.40
MEN1 O00255 3/20 0.40
ALDH1A1 P00352 1/20 0.39
GLA P06280 1/20 0.39
GAA P10253 1/20 0.39
CASP1 P29466 1/20 0.39
CASP7 P55210 1/20 0.39
HSD17B10 Q99714 1/20 0.39
CA12 O43570 5/20 0.38
CA9 Q16790 5/20 0.38
POLB P06746 1/20 0.38
TP53 P04637 2/20 0.37
RAF1 P04049 1/20 0.37
MAP2K1 Q02750 1/20 0.37
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14161472 0.87 KDM4E (0.41) NPC1RAB9AKDM4EMAPTKMT2A
SCHEMBL14579885 0.87 KDM4E (0.52) NPC1KDM4EKMT2AMEN1ALDH1A1
SCHEMBL8808484 0.87 KDM4E (0.52) NPC1KDM4EKMT2AMEN1ALDH1A1
SCHEMBL23155090 0.85 KDM4E (0.40) NPC1RAB9AKDM4EMAPTKMT2A
SCHEMBL19603987 0.85 KDM4E (0.42) NPC1RAB9AKDM4EMAPTKMT2A
SCHEMBL19269156 0.85 KDM4E (0.41) NPC1RAB9AKDM4EMAPTKMT2A
SCHEMBL25712529 0.84 KDM4E (0.46) NPC1RAB9AKDM4EMAPTKMT2A
SCHEMBL15788790 0.84 TP53 (0.43) NPC1RAB9AMAPTKMT2AMEN1
SCHEMBL23762520 0.83 KDM4E (0.39) NPC1RAB9AKDM4EMAPTKMT2A
SCHEMBL17695455 0.83 KDM4E (0.46) NPC1RAB9AKDM4EKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230193361-A1 METHODS AND COMPOSITIONS USEFUL FOR NUCLEIC ACID SEQUENCING FIRST-CITIZENS BANK & TRUST COMPANY 2023-06-22 US disclosed
WO-2023107673-A2 CLEAVABLE DISULFIDE LINKERS AND USES THEREOF Singular Genomics Systems, Inc. (US) 2023-06-15 WO disclosed
WO-2022271970-A1 METHODS AND COMPOSITIONS USEFUL FOR NUCLEIC ACID SEQUENCING Singular Genomics Systems, Inc. (US) 2022-12-29 WO disclosed
US-11352502-B2 Polymeric tandem dyes with linker groups Sony Group Corporation (JP) 2022-06-07 US disclosed
US-20210285953-A1 POLYMERIC DYES HAVING A BACKBONE COMPRISING ORGANOPHOSPHATE UNITS Sony Group Corporation (JP) 2021-09-16 US disclosed
US-20210253864-A1 POLYMERIC TANDEM DYES WITH LINKER GROUPS Sony Group Corporation (JP) 2021-08-19 US disclosed
US-11001886-B2 3′-OH unblocked, fast photocleavable terminating nucleotides and methods for nucleic acid sequencing AGILENT TECHNOLOGIES, INC. (US) 2021-05-11 US disclosed
US-20190127790-A1 3'-OH UNBLOCKED, FAST PHOTOCLEAVABLE TERMINATING NUCLEOTIDES AND METHODS FOR NUCLEIC ACID SEQUENCING AGILENT TECHNOLOGIES, INC. 2019-05-02 US disclosed
US-10041115-B2 3′-OH unblocked, fast photocleavable terminating nucleotides and methods for nucleic acid sequencing LASERGEN, INC. (US) 2018-08-07 US disclosed
US-20170327886-A1 3'-OH UNBLOCKED, FAST PHOTOCLEAVABLE TERMINATING NUCLEOTIDES AND METHODS FOR NUCLEIC ACID SEQUENCING LASERGEN, INC. (US) 2017-11-16 US disclosed
US-9689035-B2 3′-OH unblocked, fast photocleavable terminating nucleotides and methods for nucleic acid sequencing LASERGEN, INC. (US) 2017-06-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11352502-B2 Polymeric tandem dyes with linker groups CHRM1, IK, TMT1A NPC1 4754/4885RAB9A 3055/4885KDM4E 3566/4885
US-20190127790-A1 3'-OH UNBLOCKED, FAST PHOTOCLEAVABLE TERMINATING NUCLEOTIDES AND METHODS FOR NUCLEIC ACID SEQUENCING RNGTT, NT5C3B, NSUN2 NPC1 4039/4885RAB9A 4048/4885KDM4E 1347/4885
US-10041115-B2 3′-OH unblocked, fast photocleavable terminating nucleotides and methods for nucleic acid sequencing RNGTT, NT5C3B, NSUN2 NPC1 4046/4885RAB9A 4039/4885KDM4E 1357/4885
US-11001886-B2 3′-OH unblocked, fast photocleavable terminating nucleotides and methods for nucleic acid sequencing RNGTT, NT5C3B, NSUN2 NPC1 4046/4885RAB9A 4039/4885KDM4E 1357/4885
US-20170327886-A1 3'-OH UNBLOCKED, FAST PHOTOCLEAVABLE TERMINATING NUCLEOTIDES AND METHODS FOR NUCLEIC ACID SEQUENCING RNGTT, NT5C3B, NSUN2 NPC1 4039/4885RAB9A 4048/4885KDM4E 1347/4885
US-20210253864-A1 POLYMERIC TANDEM DYES WITH LINKER GROUPS CHRM1, IK, TMT1A NPC1 4754/4885RAB9A 3055/4885KDM4E 3566/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.